Archie F. S. Cullen
Directeur Général chez Solvias AG
Profil
Archie F.
S.
Cullen is currently the Chief Executive Officer at Solvias AG and also holds a current position as Vice President-Sales & Marketing at SAFC Biosciences, Inc. Previously, he was the President at BioReliance Corp.
Mr. Cullen has an undergraduate degree from the University of Glasgow and an MBA from The Open University.
Postes actifs de Archie F. S. Cullen
| Sociétés | Poste | Début |
|---|---|---|
SAFC Biosciences, Inc.
 SAFC Biosciences, Inc. Pharmaceuticals: MajorHealth Technology SAFC Biosciences, Inc. develops, manufactures, markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods. The company was acquired in 2005 by chemical supplier Sigma Aldrich Corp. The company was founded in 1971 and is headquartered in Lenexa, KA | Sales & Marketing | - |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Directeur Général | 08/03/2022 |
Anciens postes connus de Archie F. S. Cullen
| Sociétés | Poste | Fin |
|---|---|---|
BioReliance Corp.
 BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | President | - |
Formation de Archie F. S. Cullen
| University of Glasgow | Undergraduate Degree |
| The Open University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
SAFC Biosciences, Inc.
SAFC Biosciences, Inc. Pharmaceuticals: MajorHealth Technology SAFC Biosciences, Inc. develops, manufactures, markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods. The company was acquired in 2005 by chemical supplier Sigma Aldrich Corp. The company was founded in 1971 and is headquartered in Lenexa, KA | Health Technology |
BioReliance Corp.
BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | Health Technology |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
